Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Non-invasive classification & molecular subtyping of mature lymphoid neoplasms by cell-free DNA profiling

Blood (2025) 146 (Supplement 1): 5330.

https://doi.org/10.1182/blood-2025-5330

Published: 2025

Journal Articles

Non-invasive Mantle Cell Lymphoma risk stratification by inference of tumor proliferation from cfDNA

Amirsaman Ashtari, Jurik Mutter, Benoit Tessoulin, Cedric Rossi, Jan Boegeholz, Jordan Goldstein, Magdalena Klanova, Julia Kuehn, Stefan Alig, Joseph Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Marek Trneny, Steven Le Gouill, Maximilian Diehn, Mohammad Shahrokh Esfahani, Ash Alizadeh

Blood (2025) 146 (Supplement 1): 1789.

https://doi.org/10.1182/blood-2025-1789

Published: 2025

Journal Articles

Multimodal discovery of distinct tumor ecosystems for classic Hodgkin lymphoma

Shengqin Su, Ajay Subramanian, Timothy Flerlage, Jamie Flerlage, Cedric Rossi, Stefan Alig, Sheren Younes, Oscar Silva, Sandra Luna-Fineman, Natalie Park, Troy Noordenbos, Joseph Schroers-Martin, Everett Moding, Richard Hoppe, Ranjana Advani, Yasodha Natkunam, Ash Alizadeh, Michael Binkley

Blood (2025) 146 (Supplement 1): 1783.

https://doi.org/10.1182/blood-2025-1783

Published: 2025

Journal Articles

Comprehensive classification of hematological malignancies by integrating genomic and immune repertoire profiles with explainable AI

Amirsaman Ashtari, Joseph Schroers-Martin, Stefan Alig, Henning Stehr, Mohammad Shahrokh Esfahani

Blood (2025) 146 (Supplement 1): 395.

https://doi.org/10.1182/blood-2025-395

Published: 2025

Journal Articles

Early PET response for relapse prediction in 2nd or higher line lisocabtagen maraleucel in large B-cell lymphoma

Marcel Teichert, Simge Demirok, Fatma Yalinci, Stefan Alig, Keven Hoerster, Fabian Ullrich, Francesco Barbato, Ken Hermann, Hans Christian Reinhardt, Bastian von Tresckow

Blood (2025) 146 (Supplement 1): 4549.

https://doi.org/10.1182/blood-2025-4549

Published: 2025

Journal Articles

Tracing malignant precursor mutations and their cellular origins in blood and bone marrow of primary central nervous system lymphomas by ultrasensitive genomic profiling

Julia Kuehn, Christian Klingler, Samuel Weinschenk, Jurik Mutter, Fabian Hummel, Julian Rapp, Eliza Lauer, Lavanya Ranganathan, Sabine Bleul, Stefan Alig, Marco Prinz, Justus Duyster, Roman Sankowski, Maximilian Diehn, Ash Alizadeh, Elisabeth Schorb, Peter Reinacher, Florian Scherer

Blood (2025) 146 (Supplement 1): 458.

https://doi.org/10.1182/blood-2025-458

Published: 2025

Journal Articles

Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

Blood (2023) 141 (21): 2576–2586.

https://doi.org/10.1182/blood.2022019254

Published: 2023

Includes: Supplemental data

Journal Articles

Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma

Blood (2021) 138 (Supplement 1): 6.

https://doi.org/10.1182/blood-2021-149644

Published: 2021

Journal Articles

Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing

Mohammad Shahrokh Esfahani, Stefan Alig, Mahya Mehrmohamadi, Emily G. Hamilton, Daniel A King, Andre Schultz, Chloe B. Steen, Charles Macaulay, Brian Sworder, David M. Kurtz, Maximilian Diehn, Ash A. Alizadeh

Blood (2021) 138 (Supplement 1): 37.

https://doi.org/10.1182/blood-2021-150964

Published: 2021

Journal Articles

Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma

Blood (2021) 138 (Supplement 1): 233.

https://doi.org/10.1182/blood-2021-144610

Published: 2021

Journal Articles

Profiling T-Cell Receptor Diversity and Dynamics during Lymphoma Immunotherapy Using Cell-Free DNA (cfDNA)

Navika D Shukla, Alexander F. M. Craig, MPhil, Brian Sworder, MD PhD, David M. Kurtz, MDPhD, Charles Macaulay, MSc, BA, Andrea Garofalo, BS, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, George Duran, BA, Youn H. Kim, MD, James Zehnder, MD, Crystal L. Mackall, MD, David B. Miklos, MD PhD, Maximilian Diehn, MD PhD, Michael S. Khodadoust, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2020) 136 (Supplement 1): 49–50.

https://doi.org/10.1182/blood-2020-141655

Published: 2020

Journal Articles

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

Charles Macaulay, MSc, BA, Stefan Alig, MD, David M. Kurtz, MD PhD, Michael C. Jin, BS, Stephen Opat, Joanne Soo, MD, Brian Sworder, MD PhD, Mark S. Hertzberg, MD PhD, Maher K. Gandhi, PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 1600.

https://doi.org/10.1182/blood-2019-131278

Published: 2019

Journal Articles

Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling

Mohammad Shahrokh Esfahani, Stefan Alig, MD, David M. Kurtz, MD PhD, Joanne Soo, MD, Michael C. Jin, BS, Charles Macaulay, MSc, BA, Alexander F. M. Craig, MPhil, Andrea Garofalo, BS, BA, Chloe B. Steen, MSc, Florian Scherer, MD, Brian Sworder, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 551.

https://doi.org/10.1182/blood-2019-132069

Published: 2019

Journal Articles

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

David M. Kurtz, MD PhD, Joanne Soo, MD, Stefan Alig, MD, Lyron Co Ting Keh, Charles Macaulay, Michael C. Jin, BS, Florian Scherer, MD, Emily G. Hamilton, BS, Chih Long Liu, PhD, Binbin Chen, PhD, Alexander F. M. Craig, MPhil, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 552.

https://doi.org/10.1182/blood-2019-131267

Published: 2019

Journal Articles

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Brian Sworder, MD PhD, David M. Kurtz, MD PhD, Charles Macaulay, MSc, BA, Matthew J. Frank, MD PhD, Stefan Alig, MD, Andrea Garofalo, BS, BA, Bita Sahaf, PhD, Mohammad Shahrokh Esfahani, Jay Y. Spiegel, MDFRCPC, Jean Oak, MD PhD, Sara Beygi, MD, Michael C. Jin, BS, Jacob J Chabon, Michael S. Khodadoust, MD PhD, Robbie G. Majzner, MD, Crystal L. Mackall, MD, Maximilian Diehn, MD PhD, David B Miklos, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 550.

https://doi.org/10.1182/blood-2019-129015

Published: 2019

Journal Articles

Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma

Stefan Alig, MD, Charles Macaulay, MSc, BA, David M. Kurtz, MD PhD, Ulrich Dührsen, Prof, MD PhD, Andreas Hüttmann, MD, Michael C. Jin, BS, Brian Sworder, MD PhD, Andrea Garofalo, BS, BA, Mohammad Shahrokh Esfahani, Joanne Soo, MD, Florian Scherer, MD, Alexander Craig, MPhil, Olivier Casasnovas, MD, Jason R. Westin, MD, Gianluca Gaidano, MD PhD, Davide Rossi, MD PhD, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 491.

https://doi.org/10.1182/blood-2019-129283

Published: 2019

Journal Articles

Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

Blood (2019) 134 (Supplement_1): 657.

https://doi.org/10.1182/blood-2019-122663

Published: 2019

Journal Articles

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Blood (2018) 132 (Supplement 1): 4096.

https://doi.org/10.1182/blood-2018-99-118000

Published: 2018

Journal Articles

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

Blood (2018) 132 (16): 1695–1702.

https://doi.org/10.1182/blood-2018-03-837252

Published: 2018

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Non-invasive classification & molecular subtyping of mature lymphoid neoplasms by cell-free DNA profiling

Non-invasive Mantle Cell Lymphoma risk stratification by inference of tumor proliferation from cfDNA

Multimodal discovery of distinct tumor ecosystems for classic Hodgkin lymphoma

Comprehensive classification of hematological malignancies by integrating genomic and immune repertoire profiles with explainable AI

Early PET response for relapse prediction in 2nd or higher line lisocabtagen maraleucel in large B-cell lymphoma

Tracing malignant precursor mutations and their cellular origins in blood and bone marrow of primary central nervous system lymphomas by ultrasensitive genomic profiling

Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma

Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma

Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing

Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma

Profiling T-Cell Receptor Diversity and Dynamics during Lymphoma Immunotherapy Using Cell-Free DNA (cfDNA)

Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL

Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy

Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma

Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only